Home
/
Records
/
Fda Inspections
/
E2P4 Labs

FDA Inspection

•E2P4 Labs•September 17, 2024

FDA Inspection 1250451 - E2P4 Labs - September 17, 2024

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Record Details

This FDA Inspection record concerns E2P4 Labs, with an inspection on September 17, 2024, issued by the Dallas District Office, covering biologics.

Company: E2P4 Labs
Inspection Date: September 17, 2024
Product Type: Biologics
Office: Dallas District Office

Open in Dashboard

ID · 91e794df-cc3c-41c1-aae0-87b694efe73b

Violation Codes2

21 CFR 1271.47(a)21 CFR 1271.55(b)(3)

Full citation text and observation details available on the Dashboard.

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

[email protected]

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

FDA Inspection 1250451 - E2P4 Labs - September 17, 2024 | Global Key Solutions